secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coya Therapeutics, Inc. (COYA)
CIK:        0001835022
Form:       8-K
Filed at:   2024-11-05T23:59:59+00:00
Accession:  0001193125-24-251319
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Hideki Garren resigns from Coya board effective Nov 1, 2024
--------------------------------------------------------------------

- Dr. Hideki Garren resigned immediately to comply with new employer's policy barring board service on companies with similar therapeutic areas.
- Resignation was not due to any disagreement with Coya or its management on operations, policies, or practices.
- Board seat vacancy created; no replacement announced as of filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835022/000119312524251319/0001193125-24-251319-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835022/000119312524251319/d872629d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-251319

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer